Business Context and Reporting Period
This Form 6-K filing by Check-Cap Ltd. (referred to as Mbody AI Ltd. in metadata) covers the period of May 2018, with the report dated June 4, 2018. The company is a foreign private issuer based in Israel focused on medical technology, specifically the C-Scan device for colorectal cancer (CRC) screening.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure rather than a financial statement.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The filing focuses on a corporate update regarding clinical study progress.
Outlook, Management Commentary, and Risks
- Management Commentary: On June 2, 2018, the Company issued a press release announcing an oral presentation on the feasibility of prepless colorectal cancer screening using C-Scan.
- Clinical Progress: The presentation covered a multi-center clinical study submitted for CE Mark approval, which was received in January 2018.
- Event Details: The presentation took place at Digestive Disease Week in Washington DC from June 2-5, 2018.
- Regulatory Status: The filing incorporates the press release and an updated corporate presentation as Exhibit 99.1.
Investor Verification Checklist
- Verify the content of the oral presentation delivered at Digestive Disease Week regarding C-Scan feasibility.
- Confirm the current status of the CE Mark approval application submitted in January 2018.
- Review the attached Exhibit 99.1 for updated corporate strategy and clinical data not detailed in the Form 6-K text.
- Check subsequent filings for financial results, as this document contains no financial data.